Amyloid Light-chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Amyloid Light-chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Teclistamab-Daratumumab in AL Amyloidosis [Phase 2]
Phase 2 clinical trial evaluating the combination of teclistamab and daratumumab for amyloid light-chain (AL) amyloidosis; the study is curr…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study [NA]
This clinical trial investigates a regimen of daratumumab with hyaluronidase-fihj, pomalidomide, and dexamethasone for newly diagnosed AL (a…